{"id":31620,"date":"2025-06-13T21:43:51","date_gmt":"2025-06-13T18:43:51","guid":{"rendered":"https:\/\/corporate.remedia.ro\/farmaceutica-remedia-attended-the-forum-by-arir\/"},"modified":"2025-06-13T21:46:20","modified_gmt":"2025-06-13T18:46:20","slug":"farmaceutica-remedia-attended-the-forum-by-arir","status":"publish","type":"post","link":"https:\/\/corporate.remedia.ro\/en\/farmaceutica-remedia-attended-the-forum-by-arir\/","title":{"rendered":"Farmaceutica REMEDIA attended the Forum by ARIR"},"content":{"rendered":"<p>Farmaceutica Remedia was present today at the Forum by ARIR through our ESG officer, Cora \u021a\u0103ru\u0219. An event with substance, organized in the distinctive ARIR style &#8211; professional, applied and up up-to-date with the topics that are relevant for listed companies.<\/p>\n<p><img fetchpriority=\"high\" decoding=\"async\" class=\"aligncenter wp-image-31615 \" src=\"https:\/\/corporate.remedia.ro\/wp-content\/uploads\/2025\/06\/forum-ARIR-2-768x1024.jpg\" alt=\"\" width=\"512\" height=\"683\" srcset=\"https:\/\/corporate.remedia.ro\/wp-content\/uploads\/2025\/06\/forum-ARIR-2-768x1024.jpg 768w, https:\/\/corporate.remedia.ro\/wp-content\/uploads\/2025\/06\/forum-ARIR-2-225x300.jpg 225w, https:\/\/corporate.remedia.ro\/wp-content\/uploads\/2025\/06\/forum-ARIR-2-1152x1536.jpg 1152w, https:\/\/corporate.remedia.ro\/wp-content\/uploads\/2025\/06\/forum-ARIR-2-1536x2048.jpg 1536w, https:\/\/corporate.remedia.ro\/wp-content\/uploads\/2025\/06\/forum-ARIR-2-scaled.jpg 1920w\" sizes=\"(max-width: 512px) 100vw, 512px\" \/><\/p>\n<p>One of the key topics discussed: the gender balance in the management of listed companies, in the context of the new legislation (Law no. 11\/2025, which transposes EU Directive 2022\/2381), but also of the updates brought by the new Corporate Governance Code of the BVB and the guide recently issued by ARIR on this topic.<\/p>\n<p><img decoding=\"async\" class=\"aligncenter wp-image-31613 \" src=\"https:\/\/corporate.remedia.ro\/wp-content\/uploads\/2025\/06\/forum-ARIR-1-1024x658.jpg\" alt=\"\" width=\"752\" height=\"483\" srcset=\"https:\/\/corporate.remedia.ro\/wp-content\/uploads\/2025\/06\/forum-ARIR-1-1024x658.jpg 1024w, https:\/\/corporate.remedia.ro\/wp-content\/uploads\/2025\/06\/forum-ARIR-1-300x193.jpg 300w, https:\/\/corporate.remedia.ro\/wp-content\/uploads\/2025\/06\/forum-ARIR-1-768x493.jpg 768w, https:\/\/corporate.remedia.ro\/wp-content\/uploads\/2025\/06\/forum-ARIR-1-1536x987.jpg 1536w, https:\/\/corporate.remedia.ro\/wp-content\/uploads\/2025\/06\/forum-ARIR-1-2048x1316.jpg 2048w\" sizes=\"(max-width: 752px) 100vw, 752px\" \/><\/p>\n<p>For Remedia, these legislative and market developments are a clear signal. We are already in the process of developing a dedicated gender equity policy at governance level as part of our commitment to accountability and transparency. We see this stage not just as a formal obligation, but as an opportunity for internal reflection and balanced building &#8211; realistically, with concrete steps.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Farmaceutica Remedia was present today at the Forum by ARIR through our ESG officer, Cora \u021a\u0103ru\u0219. An event with substance, organized in the distinctive ARIR style &#8211; professional, applied and up up-to-date with the topics that are relevant for listed companies. One of the key topics discussed: the gender balance in the management of listed [&hellip;]<\/p>\n","protected":false},"author":9,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[160],"tags":[],"class_list":["post-31620","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/corporate.remedia.ro\/en\/wp-json\/wp\/v2\/posts\/31620","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/corporate.remedia.ro\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/corporate.remedia.ro\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/corporate.remedia.ro\/en\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/corporate.remedia.ro\/en\/wp-json\/wp\/v2\/comments?post=31620"}],"version-history":[{"count":2,"href":"https:\/\/corporate.remedia.ro\/en\/wp-json\/wp\/v2\/posts\/31620\/revisions"}],"predecessor-version":[{"id":31622,"href":"https:\/\/corporate.remedia.ro\/en\/wp-json\/wp\/v2\/posts\/31620\/revisions\/31622"}],"wp:attachment":[{"href":"https:\/\/corporate.remedia.ro\/en\/wp-json\/wp\/v2\/media?parent=31620"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/corporate.remedia.ro\/en\/wp-json\/wp\/v2\/categories?post=31620"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/corporate.remedia.ro\/en\/wp-json\/wp\/v2\/tags?post=31620"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}